Inhomogeneity of pulmonary perfusion during sustained microgravity on SLS-1.
We studied the effects of gravity on the inhomogeneity of pulmonary perfusion in humans by performing hyperventilation-breath-hold single-breath measurements before, during, and after 9 days of continuous exposure to microgravity during the Spacelab Life Sciences-1 (SLS-1) mission. In microgravity the indicators of inhomogeneity of perfusion, especially the size of cardiogenic oscillations in expired CO2 and the height of phase IV, were markedly reduced. Cardiogenic oscillations were reduced to approximately 60% of their preflight standing size, and the height of phase IV was between 0 and -8% (a terminal fall became a small terminal rise) of the preflight standing value. The terminal change in expired CO2 was nearly abolished in microgravity, indicating more uniformity of blood flow between lung units that close and those that remain open at the end of expiration. A possible explanation of this observation is the disappearance of gravity-dependent topographic inequality of blood flow. The residual cardiogenic oscillations in expired CO2 imply a persisting inhomogeneity of perfusion in the absence of gravity, probably in lung regions that are not within the same acinus.
Prisk
G K
GK
Department of Medicine, University of California, San Diego, La Jolla 92093-0931.
Guy
H J
HJ
Elliott
A R
AR
West
J B
JB
D000328:Adult; D002245:Carbon Dioxide / Q000097:blood; D005260:Female; D005652:Functional Residual Capacity / Q000502:physiology; D006321:Heart / Q000502:physiology; D006801:Humans; D006985:Hyperventilation / Q000503:physiopathology; D008297:Male; D013058:Mass Spectrometry; D008875:Middle Aged; D011652:Pulmonary Circulation / Q000502:physiology*; D011659:Pulmonary Gas Exchange / Q000502:physiology; D013026:Space Flight; D014109:Total Lung Capacity / Q000502:physiology; D014797:Vital Capacity / Q000502:physiology; D014893:Weightlessness / Q000009:adverse effects*
D002245:Carbon Dioxide